Procos is an Italian-based company that is wholly owned subsidiary of CBC Co Ltd Group, founded in 1945, producing Active Ingredients and intermediates for the pharmaceutical market, in the Generic and custom manufacturing field. Company's core know-how is high pressure technology- catalytic hydrogenations, carboxylations, reductive aminations and cryogenic reaction. Manufacturing and scaling up process are performed according to full cGMP and strict program of environmental and processes safety. Newly established "GMP-kilolab factory" allows us to expand scale-up capabilities. Production...

  • IT
  • 2015
    On CPHI since
  • 1
  • 250 - 499
Company types
Pharmaceutical company
Primary activities
API Producer
Contact info
Meet us at

CPHI North America 2023

Pennsylvania Convention Center, Philadelphia
April 25 - 27, 2023

CPHI Barcelona 2023

Fira Barcelona Gran Via, Spain
24-26 October 2023

Products from PROCOS SPA (5)

PROCOS SPA Resources (2)

  • News HPAPI Plant in Procos

    State of the art facility to develop and manufacture High Potent cytotoxic drugs. New unit for High potent APIs and intermediates (HPAPI), fully integrated on PROCOS site with dedicated facilities from R&D to cGMP production.
  • Video Procos at CPHI Worldwide 2018

    Dr. Enrico Zodio, CEO of Procos S.p.a, speaks with CPHI TV at CPHI Worldwide in Madrid.